Lung cancer
Conditions
Interventions
First biopsy is performed using 22G needle by trainer Second biopsy is performed using 25G needle by trainee
First biopsy is performed using 22G needle by trainee Second biopsy is performed using
Sponsors
National Cancer Center Hospital East Depertment of Thoracic Oncology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Suspected lung cancer based on chest CT or already diagnosised of lung cancer 2.Patients with EBUS-TBNA puncturable mediastinal and hilar lymphadenopathy with 10 or more of short diameter by chest CT or SUV-max 2.5 or more by PET-CT. 3.Patients who have mediastinal and hilar lymphadenopathy suspected to have obvious lung cancer lymph node metastasis 4.Patients in need of tissue biopsy with EBUS-TBNA. 5.Patients with an age of 20 years or older 6.Patients who obtained written informed consent
Exclusion criteria
Exclusion criteria: 1.Patients who need multiple lymph node punctures. 2.Patients with hypersensitivity to lidocaine, midazolam, flumazenil, pethidine hydrochloride, or patients with severe hypersensitivity to other drugs. 3.Patients who have clinical symptoms that are interfere in performing bronchoscopy. 4.Patients using antiplatelet drugs or anticoagulants. (It is acceptable if there is an appropriate withdrawal period) 5.Patients judged to be inappropriate by the attending physician. 6.Patients who have participated in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The result of comparing of the the diagnostic accuracy of EBUS-TBNA with a 22-gauge and a 25-gauge aspiration needle in the historogically diagnosis of malignant tumor | — |
Countries
Japan
Contacts
Public ContactTetsuya Sakai
National Cancer Center Hospital East Depertment of Thoracic Oncology
Outcome results
None listed